Profile: Indivior

Return

Indivior is a global pharmaceutical company working to help change patients’ lives by pioneering life-transforming treatment for addiction and other serious mental illnesses. Indivior manufactures and markets medicines for the treatment of moderate to severe opioid use disorder with a global portfolio in over 40 countries. Indivior also markets medicine for the treatment of schizophrenia in adults in the United States. Indivior strives to further the understanding of addiction and other serious mental health diseases.

  • Ashley Rimay, PharmD, BCPS, BCMAS
    Field Therapeutic Lead, OUD
    Senior Medical Science Liaison, Southern/Central New England
  • Stephanie Garland, PharmD, MBA, CSPI
    Medical Outcomes & Value Liaison - West
[ Feedback → ]